Euphrates Vascular is a startup based in the United States.
Euphrates Vascular is a startup based in the United States.
Euphrates Vascular develops the Pulse NanoMED™ system, a nanoscale medical device that treats distal vascular occlusions in conditions such as acute ischemic stroke, STEMI, and peripheral arterial disease by using magnetically controlled iron-oxide nanoparticles to disrupt clots unreachable by current catheter-based treatments.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.